Mycophenolate Mofetil in Systemic Sclerosis
NCT00433186
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Diffuse Cutaneous Systemic Sclerosis
Interventions
DRUG:
Mycophenolate Mofetil
Sponsor
Boston University
Collaborators
[object Object]